Microsoft is pushing AI agents deep into Windows, reviving a platform strategy that once made the OS dominant. The question ...

China has successfully deployed the world’s largest power-generating kite, capable of harnessing the potential of energy-dense, high-altitude winds to provide cheaper power than traditional surface ...

Kite, an artificial intelligence (AI)-powered payments blockchain, rolled out its native token on Monday, generating significant trading volume on South Korean exchanges Upbit and Bithumb. The token ...

Online stock brokerage platform Zerodha gave a sneak peek into the 'terminal mode' for its fast trading application and platform Kite on Friday via a post on social media platform X. The terminal mode ...

Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bertjan Pot, Liesbeth Abbenes and Maurice Scheltens are gathered in The Hague’s Museum Voorlinden after hours.

The Kite Loft's 47th annual Sunfest Kite Festival will take place in Ocean City, Maryland, from September 18-21, 2025. The festival will feature a variety of uniquely shaped kites, including dragons, ...

Trump flags fly on the storefront display of Kligs Kites at Broadway at the Beach. Jason Lee [email protected] Bruce Kilgman was a fixture in the Grand Strand community. A co-founder of the beloved ...

The round, co-led by General Catalyst and PayPal Ventures, brings the San Francisco-based startup’s cumulative funding to $33 million, according to an emailed announcement on Tuesday. Formerly known ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...